Physician
Nephrology
Dr. Errol D. Crook, MD
Errol Crook works in the field of Nephrology. He studied medicine at University of Alabama Medical Center. University of Alabama Medical Center is ranked 37/17 in Research/PrimaryCare. He received 1 awards: "Regional Top Doctor". Errol Crook is a published doctor. He has 83 papers published. The most current publication "Regulation of glutamine:fructose-6-phosphate amidotransferase by cAMP-dependent protein kinase." Errol D. Crook, MD accepts all Medicare patients.
Publications
- Sex, weight status, and chronic Kidney disease among african americans: the jackson heart study.
- Transferability and fine mapping of type 2 Diabetes loci in African Americans: the Candidate Gene Association Resource Plus Study.
- Weight Status and High Blood Pressure Among Low-Income African American Men.
- Association of socioeconomic status and CKD among African Americans: the Jackson Heart Study.
- Providing continuity of care for Chronic diseases in the aftermath of Katrina: from field experience to policy recommendations.
- A review of interventions to reduce health disparities in cardiovascular Disease in African Americans.
- Insuring continuity of care for Chronic disease patients after a disaster: key preparedness elements.
- Health disparities in Chronic diseases: where the money is.
- Using zip code-level mortality data as a local health status indicator in Mobile, Alabama.
- Cardiovascular complications of respiratory Diseases.
- Glycemic control predicts diabetic extrarenal microvascular complications but not renal survival in patients with moderate to severe chronic Kidney disease.
- Hepatitis C is a predictor of poorer Renal survival in diabetic patients.
- Effects of steroids in focal segmental glomerulosclerosis in a predominantly African-American population.
- Diabetic nephropathy in African-American patients.
- Hexosamines and TGF-beta1 use similar signaling pathways to mediate matrix protein synthesis in mesangial cells.
- Medical errors and the trainee: ethical concerns.
- Relative effects of angiotensin converting enzyme inhibitors and Calcium antagonists in advanced diabetic nephropathy.
- Using the right medication to lower blood pressure and chance for Kidney disease.
- Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers in Diabetic nephropathy? ACE inhi...
- Angiotensin-converting enzyme genotype in blacks with diabetic nephropathy: effects on risk of Diabetes and its complications.
- Are low target blood pressure goals justified in persons with Diabetes mellitus?
- Traditional and nontraditional risk factors for cardiovascular and renal Disease in African Americans (Part 2): a project of the Jackson Heart Study investigators.
- From 1960s Evans County Georgia to present-day Jackson, Mississippi: an exploration of the evolution of cardiovascular Disease in African Americans.
- Potential role of increased iron stores in Diabetes.
- Lipid abnormalities and renal Disease: is dyslipidemia a predictor of progression of renal Disease?
- Overexpression of the complementary DNA for human glutamine:fructose-6-phosphate amidotransferase in mesangial cells enhances glucose-induced fibronectin synthesis and...
- Advanced diabetic nephropathy disproportionately affects African-American females: cross-sectional analysis and determinants of Renal survival in an academic Renal cli...
- For the patient. African-American women at risk of diabetes and Kidney disease. Advanced diabetic nephropathy disproportionately affects African-American females: cros...
- Ethical issues in transplantation: living related donation in the setting of severe neurological damage Without brain death.
- Traditional and non-traditional risk factors for cardiovascular and renal Disease in African Americans: a project of the Jackson Heart Study investigators.
- Obesity, physical inactivity, and risk for cardiovascular Disease.
- Mechanisms of obesity-associated cardiovascular and renal Disease.
- Primary renal Disease as a cardiovascular risk factor.
- Kidney disease in African Americans: genetic considerations.
- Screening and prevention of chronic Kidney disease.
- Diabetic renal Disease in African Americans.
- The genetics of human Hypertension.
- Caring for adolescent family members of physician colleagues.
- Addressing cardiovascular Disease in patients with renal Disease.
- Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for Diabetic nephropathy? A case ...
- Errol Crook, MD.
- Social environmental stressors, psychological factors, and Kidney disease.
- Spinal abscess With cord compression complicating infected subclavian cannula.
- Prevention of Hypertension and its complications: theoretical basis and guidelines for treatment.
- Determinants of blood pressure Response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial.
- Distinct component profiles and high risk among African Americans With metabolic syndrome: the Jackson Heart Study.
- Prevalence and awareness of CKD among African Americans: the Jackson Heart Study.
- Dietary assessment in African Americans: methods used in the Jackson Heart Study.
- Hexosamine-induced fibronectin protein synthesis in mesangial cells is associated With increases in cAMP responsive element binding (CREB) phosphorylation and nuclear ...
- "There is power in the blood": a case discussing ethical issues of utility of resources.
- Is there hope for preventing or slowing the progression of Chronic renal disease? More support for the role of growth factors.
- The effect of enalapril on advanced Diabetic nephropathy in African-American females.
- Renal scars masquerading as complex masses in a patient With vesicoureteral reflux nephropathy.
- Diabetic nephropathy in African Americans.
- Endstage renal Disease owing to diabetic nephropathy in Mississippi: an examination of factors influencing renal survival in a population prone to late referral.
- Glucose-induced insulin resistance of phosphatidylinositol 3'-OH kinase and AKT/PKB is mediated by the hexosamine biosynthesis pathway.
- Dignity or denial? Decisions regarding initiation of dialysis and medical therapy in the institutionalized severely mentally retarded.
- Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and i...
- Regulation of glutamine:fructose-6-phosphate amidotransferase activity by high glucose and transforming growth factor beta in rat mesangial cells.
- Hexosamine regulation of glucose-mediated laminin synthesis in mesangial cells involves protein kinases A and C.
- The effects of glucose and the hexosamine biosynthesis pathway on glycogen synthase kinase-3 and other protein kinases that regulate glycogen synthase activity.
- Focal segmental glomerulosclerosis in African Americans: effects of steroids and angiotensin converting enzyme inhibitors.
- Overexpression of glutamine:fructose-6-phosphate amidotransferase in rat-1 fibroblasts enhances glucose-mediated glycogen accumulation via suppression of glycogen phos...
- Transcriptional regulation of transforming growth factor beta1 by glucose: investigation into the role of the hexosamine biosynthesis pathway.
- Insulin stimulation of glutamine: fructose-6-phosphate amidotransferase occurs via an insulin-like growth factor-1 pathway in rat fibroblasts.
- Rapid respiratory deterioration and sudden death due to disseminated cryptococcosis in a patient With the acquired immunodeficiency syndrome.
- The role of hypertension, obesity, and diabetes in causing renal vascular Disease.
- Regulation of glutamine:fructose-6-phosphate amidotransferase by cAMP-dependent protein kinase.
- Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance.
- Hexosamines and insulin resistance.
- Regulation of glycogen synthase and protein phosphatase-1 by hexosamines.
- Regulation of insulin-stimulated glycogen synthase activity by overexpression of glutamine: fructose-6-phosphate amidotransferase in rat-1 fibroblasts.
- Regulation of glycogen synthase by glucose, glucosamine, and glutamine:fructose-6-phosphate amidotransferase.
- Rapid renal deterioration secondary to oxalate in a patient With diabetic gastroenteropathy.
- Issues in developing the medical scientist, part 1: interview With Dr. Robert W. Schrier, MD.
- Issues in developing the medical scientist: introduction to the series.
- Higher prevalence of anemia with diabetes mellitus in moderate Kidney insufficiency: The Kidney Early Evaluation Program.
- Transforming growth factor-beta1 regulation of laminin gamma1 and fibronectin expression and survival of mouse mesangial cells.
- The effects of blood pressure and lipid control on Kidney allograft outcome.
- Thiazolidinediones and progression of renal Disease in patients with diabetes.
- An analysis of high glucose and glucosamine-induced gene expression and oxidative stress in Renal mesangial cells.
- Is the grass greener? From health statistics to policy decisions.
Schools
Columbia University College Of Physicians and Surgeons
University Ala Hospital
Procedures Preformed
- Arteriovenostomy for Renal Dialysis
- Biopsy
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Alkalosis
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
University of Alabama Medical Center -
Columbia University College of Physicians & Surgeons
Drug Facts
| NPI NUMBER | 1235181181 | |
| NPPES Provider LastName | CROOK | |
| NPPES Provider FirstName | ERROL | |
| NPPES Provider ZIPCode | 366172238 | |
| NPPES Provider State | AL | |
| Specialty Description | Nephrology | |
| Total Claim Count | 676.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1235181181 |
| Last Name Of The Provider | CROOK |
| First Name Of The Provider | ERROL |
| View All |
Similar Doctors
|
Dr. Ronald L. Gaines, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. F D. Scott IV, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Roy M. Culpepper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maryella D. Sirmon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen P. Wilber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wanda G. Kirkpatrick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher D. Mire, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory Rutecki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan B. Cole, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert M. Huddle, MD
This Doctor is OpenDoctor Recommended.
|